WASHINGTON – Senate lawmakers are set to unveil draft legislation as soon as Monday that will reform the FDA’s regulation of dietary supplements, cosmetic products, and certain lab-based tests, three lobbyists and a senior aide on the Senate health committee confirmed to STAT.
The policies will be included in the Senate Health, Education, Labor and Pensions Committee’s version of the legislation that sets out the fees industry pays to have the Food and Drug Administration regulate their products, known as user fee reauthorization legislation. The current funding agreement expires at the end of September.
Create a display name to comment
This name will appear with your comment